Target intelligence / Profile preview

Parasite-specific GABA-gated chloride channel

Molecular classification
Ion channel, Ligand-gated ion channel, Receptor, Cys-loop receptor family
01

Overview

Parasite-specific GABA-gated chloride channels are ligand-gated ion channels found predominantly in nematodes (parasitic worms) that mediate inhibitory neurotransmission by allowing chloride ion inflow in response to GABA (gamma-aminobutyric acid) binding, resulting in hyperpolarization and muscle relaxation[1]. These channels are essential for the control of parasite muscle tone and movement and represent a validated therapeutic target for anthelmintics. The classic anthelmintic drug piperazine acts as an agonist at these channels, causing flaccid paralysis in nematodes and facilitating their expulsion[1]. Macrocyclic lactones may also interact with these channels, but their exact mode of action is more established at glutamate-gated chloride channels[1][2]. There is some pharmacological evidence for cyclooctadepsipeptides (e.g., PF1022A, emodepside) interacting with nematode GABA receptors, though not as classical agonists[1]. These channels are members of the Cys-loop ligand-gated ion channel superfamily and are structurally distinct from mammalian GABA-A receptors, providing parasite selectivity and thus a therapeutic window. Schistosomes (flatworms) do not possess clear genes encoding GABA-gated chloride channels, restricting this target to nematodes[1]. Safety concerns primarily relate to potential cross-reactivity with host receptors, though drugs are designed for parasite selectivity, and to the emergence of drug resistance.

Other names
GABA-gated chloride channel (parasite)Nematode GABA-gated chloride channelHelminth GABA receptor (chloride channel subtype)
02

Mechanism of action

Agonism (e.g., piperazine acts as an agonist, causing channel opening and subsequent muscle relaxation/flaccid paralysis in parasites); Allosteric modulation (possible for macrocyclic lactones; precise action may vary between compounds)

03

Biological functions

Inhibitory neurotransmissionRegulation of neuromuscular activityMediation of muscle relaxation
04

Disease associations

InfectionParasitic disease
05

Safety considerations

Off-target effects in host (mammalian) GABAergic systems are a potential concern, though parasite specificity reduces riskResistance development in parasite populations
06

Interacting drugs

Piperazine

2 more in the full profile.

Beyond the preview

Go deeper on Parasite-specific GABA-gated chloride channel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parasite-specific GABA-gated chloride channel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call